Dr. A.S. The Q3 2025 Earnings Conference Call of Reddy’s Laboratories Limited (NYSE:RDY) will be held on January 23, 2025 at 9:00 AM ET
Company Participants
Richa Periwal – Head-Investor Relations and Analytics
Erez Israeli – Chief Executive Officer
M V Narasimham – Chief Financial Officer
Conference Call Participants
Kunal Dhamesha – Macquarie
Neha Manpuria – Bank of America
Amey Chalke – JM Financial
Bino Pathiparampil – Elara Capital
Surya Narayan Patra – PhillipCapital
Damayanti Sunshade – HSBC
Tushar Manudhane – Motilal Oswal Financial Services
Saion Mukherjee – Nomura
Foim Parekh – Bank of Baroda Capital Market
Anubhav Agrawal – UBS
Vishal Manchanda – Systematix
Shashank Krishnakumar – Emkay Global
Operator
Ladies and gentlemen, good day and welcome to the Quarter Three FY 2025 Earnings Conference Call of Dr. Reddy’s Laboratories Limited. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions)
I now hand the conference over to Ms. Richa Periwal. Thank you and over to you ma’am.
Richa Periwal
Thank you. A very good morning and good evening to all of you, and thank you for joining us today for the Dr. Reddy’s Q3 FY 2025 earnings conference call. We have with us the leadership team of Dr. Reddy’s comprising Mr. Erez Israeli, our CEO; Mr. M V Narasimham, our CFO; and the Investor Relations team.
Earlier today, we have released our results, and the same is also posted on our website. We will kick off today’s call with MVN taking us through the financial highlights of the quarter. This will be followed by Erez, sharing his thoughts on business performance. Post which, we will open the forum for Q&A. Please note that today’s call is a copyrighted material of Dr. Reddy’s and cannot be rebroadcasted or attributed in press or media outlets without the Company’s
GIPHY App Key not set. Please check settings